NCT02986932View on ClinicalTrials.gov

Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Alzheimer Disease
Interventions
DEVICE

BBB opening

Open BBB using ExAblate focused ultrasound and (Definity®) contrast agent

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY